ChromoTek anti-IL6 recombinant VHH, CoraLite ® Plus 555

CL555-IL6 is a recombinant CoraLite ® Plus 555 conjugated anti IL6 Nanobody (VHH) that targets IL6 in IF and FC applications, showing reactivity with human samples.
Cat No. CL555-IL6

Host/Type

Alpaca VHH

Reactivity

Human

Applications

IF, FC

Conjugate

CoraLite® Plus 555

IL-6 VHH, IL-6 single domain antibody (sdAb), Interleukin 6, BSF-2, CDF

规格价格库存


Product Information

CL555-IL6 is a recombinant CoraLite ® Plus 555 conjugated anti IL6 Nanobody (VHH) that targets IL6 in IF and FC applications, showing reactivity with human samples.

ApplicationsIF, FC
ReactivityHuman
ConjugateCoraLite® Plus 555
TypeNanobody
ClassRecombinant
HostAlpaca
Affinity3 nM
Molecular Weight14.1 kDa
FormLiquid
Excitation/Emission Maxima Wavelengths554 nm / 570 nm
RRIDAB_3665391
Storage Buffer10 mM HEPES pH 7.0, 500 mM NaCl, 5 mM EDTA, 0.09% sodium azide
Storage ConditionStore at -20°C
Shippingblue ice
BackgroundInterleukin-6 (IL-6) is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine. IL-6 protein is secreted by a variety of cell types including T cells and macrophages as phosphorylated and variably glycosylated molecule. IL-6 plays an essential role in the final differentiation of B-cells into Ig-secreting cells involved in lymphocyte and monocyte differentiation. It induces myeloma and plasmacytoma growth and induces nerve cells differentiation acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. IL-6 is also considered a myokine, a cytokine produced from muscle, and is elevated in response to muscle contraction. IL-6 has been shown to interact with interleukin-6 receptor and glycoprotein 130. Additionally, IL-6 is involved in hematopoiesis, bone metabolism, and cancer progression, and has been defined an essential role in directing transition from innate to acquired immunity.